Schneider Joseph R
Central DuPage Hospital, Winfield, IL, USA.
Perspect Vasc Surg Endovasc Ther. 2009 Dec;21(4):214-7. doi: 10.1177/1531003509359312. Epub 2010 Jan 21.
Infrainguinal arterial bypass with autologous vein has proven effective and durable over nearly 60 years. Less invasive endovascular treatment has emerged as a formidable competitor to the vein bypass. In many, if not most cases, the choice of one modality over the other is clear. However, there are situations where the decision is not so obvious. It is in such cases that the careful consideration of all patient and anatomic factors by the experienced vascular specialist who can offer both open surgical bypass and endovascular treatment is likely to lead to better outcomes. This article and presentation will attempt to provide some guidelines that the reader may consider when making such choices.
近60年来,自体静脉腹股沟下动脉搭桥术已被证明是有效且持久的。侵入性较小的血管内治疗已成为静脉搭桥术的强大竞争对手。在许多(如果不是大多数)情况下,选择一种治疗方式而不是另一种治疗方式是明确的。然而,在某些情况下,决策并非如此明显。正是在这种情况下,经验丰富的血管专家(既能提供开放手术搭桥又能进行血管内治疗)仔细考虑所有患者和解剖因素,可能会带来更好的结果。本文及演讲将尝试提供一些读者在做出此类选择时可考虑的指导原则。